What is Curanex Pharmaceuticals Inc Common Stock?
Curanex Pharmaceuticals Inc, a developmental stage pharmaceutical company, discovers, develops, and commercializes botanical drugs to treat patients with inflammatory diseases.
The story behind the price, the case for and against, and what could go wrong. Open a part to read it.
Curanex Pharmaceuticals Inc, a developmental stage pharmaceutical company, discovers, develops, and commercializes botanical drugs to treat patients with inflammatory diseases. It develops Phyto-N for various therapeutic areas, including ulcerative colitis, atopic dermatitis, COVID-19, diabetes, nonalcoholic fatty liver disease, and gout. The company is listed on the NASDAQ in USA, operating in the Healthcare sector, with a market capitalisation of 6.96M.
A short list of Biotechnology names that are close enough in size to make side-by-side comparison useful.